AGTR1 Inhibits the Progression of Lung Adenocarcinoma

Lecai Xiong1, Yanhong Wei2, Xiao Zhou1

  • 1Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People's Republic of China.

Abstract

Insights

The angiotensin II receptor 1 (AT1R) gene, AGTR1, inhibits lung adenocarcinoma (LUAD) progression. High AGTR1 expression correlates with better prognosis and an anti-tumor immune microenvironment, acting via the PI3K/AKT3 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Lung adenocarcinoma (LUAD) development is multifactorial.
  • The renin-angiotensin system (RAS) is implicated in lung cancer.
  • The angiotensin II receptor 1 (AT1R) gene, AGTR1, is a key RAS component.

Purpose of the Study:

  • To investigate the role of AGTR1 in pan-cancer, with a focus on LUAD.
  • To explore the association of AGTR1 with clinicopathological features, prognosis, and the tumor microenvironment in LUAD.
  • To elucidate the underlying mechanism of AGTR1 action in LUAD.

Main Methods:

  • Comprehensive analysis of AGTR1 expression in The Cancer Genome Atlas (TCGA) pan-cancer dataset.
  • Correlation analysis of AGTR1 with LUAD clinicopathological features, prognosis, and immune cell infiltration using TCGA and GEO databases.
  • Functional mechanism exploration via enrichment analysis and in vitro/tissue sample validation.

Main Results:

  • AGTR1 expression is reduced in most cancers and linked to prognosis.
  • In LUAD, high AGTR1 expression is associated with better prognosis, reduced lymph node metastasis, and MET mutation.
  • High AGTR1 expression correlates with an anti-tumor immune microenvironment (increased B cells, dendritic cells, monocytes; decreased MDSCs) and involves the PI3K/AKT3 pathway.

Conclusions:

  • AGTR1 acts as a tumor suppressor in LUAD.
  • AGTR1 inhibits LUAD progression, potentially through the PI3K/AKT3 signaling pathway.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.1K